The Centers for Medicare & Medicaid Services' just-released 2015 Managed Care Rate Setting Consultation Guide as guidance this year for states that expanded Medicaid.
State standards for access to care for those enrolled in Medicaid managed care programs varies greatly, according to a new report from the Office of the Inspector General.
Policy experts and lawmakers say that state officials can take certain steps to help drive insurers to lower their premium rates, including reviewing proposed rates and expanding Medicaid, reported Governing.
The health insurance payment system is broken and the Affordable Care Act, which was supposed to lower costs, is actually contributing to the problem, MVP Health Care CEO Denise Gonick, told the Albany Business Review.
There have been a lot of changes to Medicare Advantage plans of late--UnitedHealth dropped providers in Alabama, Humana lost a big provider contract and MVP Health Care is discontinuing two of its plans.
Individuals in states that ceded all enforcement of the Affordable Care Act were worse off by approximately $245 per participant on an annualized basis, according to a recent study from Amanda Kowalski, published by the Brookings Institution.
Medicaid: to expand or not to expand? That is the question for the 24 states who opted out of the 2012 ruling under the Affordable Care Act. But for the 26 states, and the District of Columbia, who chose to extend the option to lower-income residents, the uninsured rate has dropped, while hospital admissions has increased, finds a new report from PwC's Health Research Institute.
There's been a lot of action throughout the states ahead of the next open enrollment period for health insurance exchanges. Meanwhile, some state officials are still considering whether to expand their Medicaid programs. Here's a roundup of the recent news across states.
When Medicaid programs provide higher reimbursements for doctors' office visits, Medicaid members are more likely to receive cancer screenings for breast, cervical and colorectal cancers, according to a study published in the journal, Cancer.
Medicaid insurers are struggling to pay for pricey drugs, leading some to request states to increase payments so they can run their plans. Meanwhile, some states are deciding restrict the expensive medications.